TTOO Prakiraan rega marang bathi T2 Biosystems Inc.

T2 Biosystems, Inc. (TTOO) robotic platforms automate pathogen detection, eliminating human error. The company's consensus forward P/E reflects the valuation dynamics of these technologies, where the 0.00 mark serves as a current indicator. The scaling of T2Dx systems across US clinics expands market presence, while the closed cartridge ecosystem ensures customer retention despite slow FDA approvals and prolonged hospital budget cycles.

TTOO - Kapitalisasi marang proyeksi bathi t2biosystems.com ing rentang 04.07.2022 - 22.02.2025

Rincian metrik keuangan lan pasar T2 Biosystems Inc (TTOO)

- nilai saham lan prakiraan konsensus rega:

Bagan rega T2 Biosystems|TTOO - Target median analis

- data kapitalisasi pasar:

Biji pasar T2 Biosystems Inc.|TTOO - Total Nilai Bisnis

- statistik nilai buku emiten:

Nilai Buku saben Saham T2 Biosystems|TTOO - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku t2biosystems.com|TTOO - Gunggung Aset Perusahaan

- informasi babagan utang lan solvabilitas:

Rasio Total Utang marang Ekuitas T2 Biosystems, Inc.|TTOO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas T2 Biosystems, Inc.|TTOO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku T2 Biosystems Inc.|TTOO - Utang jangka dawa|Utang jangka cendhak perusahaan T2 Biosystems|Rasio cepet t2biosystems.com

- statistik bathi lan rasio pasar:

TTOO - Asil keuangan resik|Proyeksi bathi mangsa ngarep T2 Biosystems, Inc.|TTOO - Koefisien rega marang bathi|Pangali Forward P/E T2 Biosystems, Inc|TTOO - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan T2 Biosystems Inc.|TTOO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan T2 Biosystems|TTOO - Bathi saben saham sajroning taun lumaku|Wutah bathi EPS kuartalan t2biosystems.com|TTOO - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep T2 Biosystems, Inc.

Analisis fundamental perusahaan:T2 Biosystems

When constructing a long-term portfolio, asset screening requires an analysis of future market earnings expectations. The ratio of the current share price to the projected EPS measures the investment premium, which for T2 Biosystems, Inc. (TTOO) is supported by flexible outsourcing of diagnostic cartridge production, as reflected in the company's consensus forward P/E trend.

Pesaing T2 Biosystems, Inc. (TTOO)

Rega marang bathi mangsa ngarep Abbott (ABT)|Kapitalisasi marang proyeksi bathi Thermo Fisher Scientific Inc.|GE Healthcare Corp - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep MTD (Mettler Toledo Inc)|Waters Corporation - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi bio-techne.com TECH|BRKR: Pangali Forward P/E|Prakiraan rega marang bathi Azenta Inc|Prakiraan rega marang bathi VREX|SMLR: Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Butterfly Network, Inc. (BFLY)|Prakiraan rega marang bathi mesalabs.com MLAB|Pangali Forward P/E QSI (Quantum-Si Incorporated)|Nano-X Imaging (NNOX) - Rasio prakiraan rega marang bathi|Quanterix Corp - Pangali Forward P/E|MASS (908 Devices Corporation) - Rasio rega marang bathi mangsa ngarep|CV: Pangali Forward P/E|MXCT - Kapitalisasi marang proyeksi bathi|RPID (Rapid Micro Biosystems Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi Seer Inc (SEER)|Pangali Forward P/E HYPR|Pangali Forward P/E FONAR Corporation Inc (FONR)|Rega marang bathi mangsa ngarep Daxor DXR|Spectral AI Inc. - Rega marang bathi mangsa ngarep|VIVS: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ACON (Aclarion Inc)|AKYA: Pangali Forward P/E|Rasio prakiraan rega marang bathi Cesca Therapeutics (THMO)|Rega marang bathi mangsa ngarep Talis Biomedical Corp.